This skill suggests using prednisolone as an alternative glucocorticoid when hydrocortisone is unavailable for emergency treatment of adrenal crisis. Dexamethasone is the least-preferred option and should only be administered if no other glucocorticoid is available.
日本語の概要は準備中です。原文の説明を表示しています。
dromlakhani/MD2SKILL☆ 132026年10月5日 更新
This skill guides annual evaluation of patients with primary adrenal insufficiency (PAI) for symptoms and signs of glucocorticoid and mineralocorticoid over- or under-replacement. Use during annual follow-up when assessing for weight changes, blood pressure abnormalities, edema, or symptoms such as fatigue, insomnia, or salt craving.
日本語の概要は準備中です。原文の説明を表示しています。
dromlakhani/MD2SKILL☆ 132026年10月5日 更新
Recommends against dexamethasone for glucocorticoid replacement in primary adrenal insufficiency (PAI) due to risk of Cushingoid side effects from difficult dose titration. Use when selecting a glucocorticoid for PAI management to avoid iatrogenic Cushing syndrome.
日本語の概要は準備中です。原文の説明を表示しています。
dromlakhani/MD2SKILL☆ 132026年10月5日 更新
Suggests avoiding synthetic, long-acting glucocorticoids (e.g., prednisolone, dexamethasone) in children with primary adrenal insufficiency (PAI). Use when selecting glucocorticoid replacement for a child with PAI to prevent Cushingoid side effects and dose titration difficulties.
日本語の概要は準備中です。原文の説明を表示しています。
dromlakhani/MD2SKILL☆ 132026年10月5日 更新